Morganella morganii: Difference between revisions
From IDWiki
Morganella morganii
Content deleted Content added
m Text replacement - "[[Cellular shape::" to "[[Shape::" |
|||
| Line 5: | Line 5: | ||
=== Microbiology === |
=== Microbiology === |
||
* [[Stain::Gram- |
* [[Stain::Gram-negative]] [[Shape::bacillus]] |
||
* Intrinsically resistant to [[ampicillin]], [[amoxicillin-clavulanic acid]], first-generation [[cephalosporins]], [[tigecycline]] (but not [[tetracyclines]]), [[nitrofurantoin]], [[colistin]] |
* Intrinsically resistant to [[ampicillin]], [[amoxicillin-clavulanic acid]], first-generation [[cephalosporins]], [[tigecycline]] (but not [[tetracyclines]]), [[nitrofurantoin]], [[colistin]] |
||
Revision as of 21:05, 2 September 2021
Background
Microbiology
- Gram-negative bacillus
- Intrinsically resistant to ampicillin, amoxicillin-clavulanic acid, first-generation cephalosporins, tigecycline (but not tetracyclines), nitrofurantoin, colistin
References
- a b T.-Y. Lin, M.-C. Chan, Y.-S. Yang, Y. Lee, K.-M. Yeh, J.-C. Lin, F.-Y. Chang. Clinical manifestations and prognostic factors of Morganella morganii bacteremia. European Journal of Clinical Microbiology & Infectious Diseases. 2014;34(2):231-236. doi:10.1007/s10096-014-2222-8.
- a b David Erlanger, Marc Victor Assous, Yonit Wiener-Well, Amos Moshe Yinnon, Eli Ben-Chetrit. Clinical manifestations, risk factors and prognosis of patients with Morganella morganii sepsis. Journal of Microbiology, Immunology and Infection. 2019;52(3):443-448. doi:10.1016/j.jmii.2017.08.010.
